What were the demographics of mRNA vaccine trial participants? What races/ethnicities were included?

For the Pfizer-BioNTech vaccine (37,586 participants in safety population):

Race/Ethnicity
- 83.1% White (31,230)
- 28.0% Hispanic/Latinx (10,522)
- 9.1% Black (3,416)
- 4.3% Asian (1,606)
- 0.5% American Indian or Alaska Native (198)
- 0.2% Native Hawaiian or other Pacific Islander (76) o
- 2.3% Multiracial (853)
Gender
- 50.6% Male (19,001)
- 49.4% Female (18,585)
Age
- Mean age 50.4 years

For the Moderna vaccine (30,350 participants in safety population):

Race/Ethnicity
- 79.2% White (24,023)
- 20.5% Hispanic/Latinx (6,234)
- 10.2% Black (3,090)
- 4.6% Asian (1,385)
- 0.8% American Indian or Alaska Native (230)
- 0.2% Native Hawaiian or other Pacific Islander (66) o 2.1% Multiracial (634)
- 2.1% Other (636)
Gender
- 52.7% Male (14,355)
- 43.3% Female (13,175)
Age
- Mean age 51.4 years
- 24.8% 65 years and older (7,520)

For the Johnson & Johnson vaccine (43,783 participants globally):

Race/Ethnicity
- 58.7% White
- 45.3% Hispanic/Latinx
- 19.4% Black
- 3.3% Asian
- 9.5% American Indian/Alaska Native
- 0.2% Native Hawaiian or other Pacific Islander
- 5.6% Multiracial
- 1.4% Unknown
Gender
- 55% Male
- 45% Female
Age
- Mean age 52 years
- 34% 60 years and older (14,672)

Sources

Updated: March 1, 2021